These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16679324)

  • 21. Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
    La Marca A; Volpe A
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):603-10. PubMed ID: 16712660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART).
    Fréour T; Mirallié S; Bach-Ngohou K; Denis M; Barrière P; Masson D
    Clin Chim Acta; 2007 Jan; 375(1-2):162-4. PubMed ID: 16860302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.
    Smeenk JM; Sweep FC; Zielhuis GA; Kremer JA; Thomas CM; Braat DD
    Fertil Steril; 2007 Jan; 87(1):223-6. PubMed ID: 17081531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status.
    Fanchin R; Louafi N; Méndez Lozano DH; Frydman N; Frydman R; Taieb J
    Fertil Steril; 2005 Jul; 84(1):167-73. PubMed ID: 16009173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females.
    Al-Qahtani A; Muttukrishna S; Appasamy M; Johns J; Cranfield M; Visser JA; Themmen AP; Groome NP
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):267-73. PubMed ID: 16117813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relevance of anti-Mullerian hormone measurement in a routine IVF program.
    Gnoth C; Schuring AN; Friol K; Tigges J; Mallmann P; Godehardt E
    Hum Reprod; 2008 Jun; 23(6):1359-65. PubMed ID: 18387961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status.
    Fanchin R; Taieb J; Lozano DH; Ducot B; Frydman R; Bouyer J
    Hum Reprod; 2005 Apr; 20(4):923-7. PubMed ID: 15640257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology.
    Silberstein T; MacLaughlin DT; Shai I; Trimarchi JR; Lambert-Messerlian G; Seifer DB; Keefe DL; Blazar AS
    Hum Reprod; 2006 Jan; 21(1):159-63. PubMed ID: 16123085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Müllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation.
    Riggs R; Kimble T; Oehninger S; Bocca S; Zhao Y; Leader B; Stadtmauer L
    Fertil Steril; 2011 Jan; 95(1):410-2. PubMed ID: 20736131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles.
    Lee TH; Liu CH; Huang CC; Wu YL; Shih YT; Ho HN; Yang YS; Lee MS
    Hum Reprod; 2008 Jan; 23(1):160-7. PubMed ID: 18000172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum anti-Müllerian hormone expression in women with premature ovarian failure.
    Méduri G; Massin N; Guibourdenche J; Bachelot A; Fiori O; Kuttenn F; Misrahi M; Touraine P
    Hum Reprod; 2007 Jan; 22(1):117-23. PubMed ID: 16954410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy.
    Hehenkamp WJ; Volkers NA; Broekmans FJ; de Jong FH; Themmen AP; Birnie E; Reekers JA; Ankum WM
    Hum Reprod; 2007 Jul; 22(7):1996-2005. PubMed ID: 17582145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum anti-Müllerian hormone levels do not predict the efficiency of testicular sperm retrieval in men with non-obstructive azoospermia.
    Isikoglu M; Ozgur K; Oehninger S; Ozdem S; Seleker M
    Gynecol Endocrinol; 2006 May; 22(5):256-60. PubMed ID: 16785146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone.
    Fleming R; Deshpande N; Traynor I; Yates RW
    Hum Reprod; 2006 Jun; 21(6):1436-41. PubMed ID: 16439501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization.
    Takahashi C; Fujito A; Kazuka M; Sugiyama R; Ito H; Isaka K
    Fertil Steril; 2008 Mar; 89(3):586-91. PubMed ID: 17543956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause.
    La Marca A; De Leo V; Giulini S; Orvieto R; Malmusi S; Giannella L; Volpe A
    J Soc Gynecol Investig; 2005 Oct; 12(7):545-8. PubMed ID: 16046154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predictive value of serum concentrations of anti-Müllerian hormone for oocyte quality, fertilization, and implantation.
    Borges E; Braga DPAF; Setti A; Figueira RC; Iaconelli A
    JBRA Assist Reprod; 2017 Sep; 21(3):176-182. PubMed ID: 28837024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of anti-mullerian hormone levels with obesity in late reproductive-age women.
    Freeman EW; Gracia CR; Sammel MD; Lin H; Lim LC; Strauss JF
    Fertil Steril; 2007 Jan; 87(1):101-6. PubMed ID: 17109858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of age-specific serum anti-Müllerian hormone concentrations.
    Barad DH; Weghofer A; Gleicher N
    Reprod Biomed Online; 2011 Mar; 22(3):284-91. PubMed ID: 21269880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Müllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome.
    Wang JG; Nakhuda GS; Guarnaccia MM; Sauer MV; Lobo RA
    Am J Obstet Gynecol; 2007 Jan; 196(1):77.e1-5. PubMed ID: 17240243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.